Drug Search Results
More Filters [+]

Cupric sulfate

Alternative Names: cupric sulfate, multrys, tralement
Latest Update: 2023-08-24
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Ceruloplasmin Cofactor,Cytochrome C Oxidase Cofactor,LOX Cofactor,SOD Cofactor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Colombia | Malaysia | Taiwan | United Arab Emirates | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: American Regent
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cupric sulfate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Other

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

TE20001

P4

Not yet recruiting

Other

2025-10-31

TE20002

P4

Not yet recruiting

Other

2025-10-31

Recent News Events